Pfizer plans to sweeten its bid for Metsera , a person familiar with the matter told Reuters, after a judge denied its ...
Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera. Novo is now offering to pay as much as $10 billion for the company, Metsera ...
-Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday. WHY ...
A strange revelation emerged for entertainment giant Warner Bros. Discovery ($WBD) today, as we discovered that the offer ...